Western Pacific Region Index Medicus

Efficacy and safety of secukinumab in Chinese patients with psoriasis: Update of six-year real-world data and a meta-analysis.

Author: He HUANG ¹ ; Yaohua ZHANG ² ; Caihong ZHU ³ ; Zhengwei ZHU ³ ; Yujun SHENG ⁴ ; Min LI ¹ ; Huayang TANG ³ ; Jinping GAO ³ ; Dawei DUAN ³ ; Hequn HUANG ³ ; Weiran LI ³ ; Tingting ZHU ³ ; Yantao DING ³ ; Wenjun WANG ³ ; Yang LI ³ ; Xianfa TANG ³ ; Liangdan SUN ⁵ ; Yanhua LIANG ⁶ ; Xuejun ZHANG ¹ ; Yong CUI ⁷ ; Bo ZHANG ¹
Author Information

1. Department of Dermatology, The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital, Medical Center of Soochow University), Suzhou, Jiangsu 215125, China.
2. Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200040, China.
3. Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China.
4. Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei, Anhui 230022, China.
5. Department of Dermatology, North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei 063000, China.
6. Department of Dermatology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong 510086, China.
7. Department of Dermatology, China-Japan Friendship Hospital, Beijing 100029, China.
Publication Type:Journal Article
From: Chinese Medical Journal 2025;138(23):3198-3200
CountryChina
Language:English